54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Jul 29
18:39 UTC
|
PGC
Peapack-Gladstone Financial
|
◎ Target | Manuel Navas ★★★★☆ #438 | Overweight | $54.00→ $58.00+7.4% |
|
Jul 29
18:39 UTC
|
OSK
Oshkosh
|
◎ Target | Michael Shlisky ★★☆☆☆ #2837 | Buy | $168.00→ $176.00+4.8% |
|
Jul 29
18:39 UTC
|
OSK
Oshkosh
|
◎ Target | Tami Zakaria ★★★☆☆ #1063 | Neutral | $145.00→ $150.00+3.4% |
|
Jul 29
18:39 UTC
|
ONON
ON
|
◎ Target | Jay Sole ★★★☆☆ #1559 | Buy | $85.00→ $82.00-3.5% |
|
Jul 29
18:39 UTC
|
NXPI
NXP Semiconductors
|
◎ Target | Joshua Buchalter ★☆☆☆☆ #2976 | Buy | $340.00→ $290.00-14.7% |
|
Jul 29
18:39 UTC
|
NVST
Envista
|
◎ Target | Jason Bednar ★★★★☆ #437 | Neutral | $25.00→ $26.00+4.0% |
|
Jul 29
18:39 UTC
|
NBTB
NBT Bancorp
|
◎ Target | Jake Civiello ★★★★★ #102 | Buy | $52.00→ $59.00+13.5% |
|
Jul 29
18:39 UTC
|
MVBF
Mvb Financial
|
◎ Target | Janet Lee ★★★★☆ #602 | Buy | $32.00→ $34.00+6.2% |
|
Jul 29
18:39 UTC
|
MTB
M&T Bank
|
◎ Target | Vivek Juneja ★★★☆☆ #1156 | Neutral | $251.50→ $265.50+5.6% |
|
Jul 29
18:39 UTC
|
MDLZ
Mondelez International
|
◎ Target | Robert Moskow ★★★★☆ #402 | Buy | $67.00→ $70.00+4.5% |
|
Jul 29
18:39 UTC
|
MDLZ
Mondelez International
|
◎ Target | Thomas Palmer ★★★☆☆ #1674 | Overweight | $70.00→ $72.00+2.9% |
|
Jul 29
18:39 UTC
|
MDGL
Madrigal Pharmaceuticals
|
◎ Target | Edward Nash ★★☆☆☆ #2435 | Buy | $578.00→ $587.00+1.6% |
|
Jul 29
18:39 UTC
|
MANH
Manhattan Associates
|
◎ Target | Clark Wright ★★★★★ #136 | Buy | $200.00→ $210.00+5.0% |
|
Jul 29
18:39 UTC
|
LSTR
Landstar System
|
◎ Target | Brian Ossenbeck ★★★☆☆ #1831 | Neutral | $198.00→ $204.00+3.0% |
|
Jul 29
18:39 UTC
|
KO
CocaCola
|
◎ Target | Mike Lavery not yet tracked | Overweight | $88.00→ $95.00+8.0% |
|
Jul 29
18:39 UTC
|
KNSA
Kiniksa Pharmaceuticals International
|
◎ Target | Anupam Rama ★★☆☆☆ #2780 | Overweight | $72.00→ $107.00+48.6% |
|
Jul 29
18:39 UTC
|
KNSA
Kiniksa Pharmaceuticals International
|
◎ Target | Edward Nash ★★☆☆☆ #2435 | Buy | $64.00→ $98.00+53.1% |
|
Jul 29
18:39 UTC
|
IVZ
Invesco
|
◎ Target | Kenneth Lee ★★★★☆ #428 | Outperform | $33.00→ $35.00+6.1% |
|
Jul 29
18:39 UTC
|
IVZ
Invesco
|
◎ Target | Kenneth Worthington not yet tracked | Neutral | $29.00→ $29.50+1.7% |
|
Jul 29
18:39 UTC
|
ITW
Illinois Tool Works
|
◎ Target | Tami Zakaria ★★★☆☆ #1063 | Overweight | $310.00→ $350.00+12.9% |
|
Jul 29
18:39 UTC
|
IQV
IQVIA
|
◎ Target | Charles Rhyee ★★★★☆ #398 | Buy | $233.00→ $288.00+23.6% |
|
Jul 29
18:39 UTC
|
IQV
IQVIA
|
◎ Target | Ryan Halsted ★★★★★ #250 | Outperform | $221.00→ $247.00+11.8% |
|
Jul 29
18:39 UTC
|
IQV
IQVIA
|
◎ Target | Casey Woodring ★★★★★ #15 | Overweight | $225.00→ $285.00+26.7% |
|
Jul 29
18:39 UTC
|
IQV
IQVIA
|
◎ Target | Shlomo Rosenbaum ★★★★★ #181 | Buy | $220.00→ $276.00+25.5% |
|
Jul 29
18:39 UTC
|
INCY
Incyte
|
◎ Target | Brian Abrahams ★★★☆☆ #2259 | Sec→ r Perform | $99.00→ $109.00+10.1% |
|
Jul 29
18:39 UTC
|
GEHC
GE HealthCare Technologies
|
◎ Target | Ryan Zimmerman ★★★☆☆ #1544 | Buy | $75.00→ $79.00+5.3% |
|
Jul 29
18:39 UTC
|
FSBC
Five Star Bancorp
|
◎ Target | Gary Tenner ★★★★★ #213 | Buy | $53.00→ $55.00+3.8% |
|
Jul 29
18:39 UTC
|
FITB
Fifth Third Bancorp
|
◎ Target | Vivek Juneja ★★★☆☆ #1156 | Overweight | $61.00→ $62.00+1.6% |
|
Jul 29
18:39 UTC
|
FHB
First Hawaiian
|
◎ Target | Janet Lee ★★★★☆ #602 | Hold | $32.00→ $31.00-3.1% |
|
Jul 29
18:39 UTC
|
FELE
Franklin Electric
|
◎ Target | Matt Summerville ★★☆☆☆ #2389 | Neutral | $100.00→ $105.00+5.0% |
|
Jul 29
18:39 UTC
|
FBNC
First Bancorp
|
◎ Target | Stephen Scouten ★★★★☆ #433 | Neutral | $64.00→ $65.00+1.6% |
|
Jul 29
18:39 UTC
|
F
Ford Motor
|
◎ Target | Rajat Gupta not yet tracked | Overweight | $16.00→ $17.00+6.2% |
|
Jul 29
18:39 UTC
|
F
Ford Motor
|
◎ Target | Itay Michaeli ★★☆☆☆ #2758 | Hold | $13.00→ $15.00+15.4% |
|
Jul 29
18:39 UTC
|
EXLS
ExlService
|
◎ Target | Mayank Tandon ★★★★☆ #415 | Buy | $40.00→ $45.00+12.5% |
|
Jul 29
18:39 UTC
|
ENPH
Enphase Energy
|
◎ Target | Christopher Dendrinos not yet tracked | Outperform | $54.00→ $47.00-13.0% |
|
Jul 29
18:39 UTC
|
CURB
Curbline Properties
|
◎ Target | Alex Goldfarb not yet tracked | Overweight | $39.00→ $40.00+2.6% |
|
Jul 29
18:39 UTC
|
CPRI
Capri
|
◎ Target | Oliver Chen ★★★★☆ #929 | Hold | $26.00→ $20.00-23.1% |
|
Jul 29
18:39 UTC
|
CORT
Corcept Therapeutics
|
◎ Target | Edward Nash ★★☆☆☆ #2435 | Buy | $135.00→ $150.00+11.1% |
|
Jul 29
18:39 UTC
|
CLS
Celestica
|
◎ Target | Joseph Cardoso ★★☆☆☆ #2685 | Overweight | $445.00→ $485.00+9.0% |
|
Jul 29
18:39 UTC
|
CFG
Citizens Financial Group
|
◎ Target | Vivek Juneja ★★★☆☆ #1156 | Overweight | $76.00→ $78.00+2.6% |
|
Jul 29
18:39 UTC
|
BSX
Boston Scientific
|
◎ Target | Marie Thibault ★★★★☆ #713 | Buy | $65.00→ $60.00-7.7% |
|
Jul 29
18:39 UTC
|
BAC
Bank of America
|
◎ Target | Vivek Juneja ★★★☆☆ #1156 | Overweight | $62.50→ $68.00+8.8% |
|
Jul 29
18:39 UTC
|
BA
Boeing
|
◎ Target | Seth Seifman ★★☆☆☆ #2694 | Overweight | $270.00→ $290.00+7.4% |
|
Jul 29
18:39 UTC
|
AMT
American Tower
|
◎ Target | Michael Elias ★★☆☆☆ #2372 | Buy | $225.00→ $227.00+0.9% |
|
Jul 29
18:39 UTC
|
ALKS
Alkermes
|
◎ Target | Jessica Fye ★★☆☆☆ #2570 | Neutral | $60.00→ $61.00+1.7% |
|
Jul 29
18:39 UTC
|
AAUC
Allied Gold
|
↓ Downgrade | firm only | Sec→ r Perform | |
|
Jul 29
17:39 UTC
|
XYL
Xylem
|
◎ Target | Brett Linzey ★★★☆☆ #2090 | Neutral | $124.00→ $130.00+4.8% |
|
Jul 29
17:39 UTC
|
XIFR
XPLR Infrastructure
|
◎ Target | Anthony Crowdell ★★★☆☆ #2040 | Neutral | $12.00→ $13.00+8.3% |
|
Jul 29
17:39 UTC
|
WIX
Wix.com
|
◎ Target | Mark Zgutowicz ★★☆☆☆ #2305 | Buy | $115.00→ $85.00-26.1% |
|
Jul 29
17:39 UTC
|
VRNS
Varonis Systems
|
◎ Target | Rob Owens ★★★★★ #36 | Overweight | $47.00→ $58.00+23.4% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.